79 related articles for article (PubMed ID: 21365510)
1. [Expression and clinical significance of epidermal growth factor receptor and protein kinase B in gastric carcinoma].
Zhang HY; Tao HM; Chen HT
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Feb; 14(2):140-2. PubMed ID: 21365510
[TBL] [Abstract][Full Text] [Related]
2. Expression of c-Cbl, Cbl-b, and epidermal growth factor receptor in gastric carcinoma and their clinical significance.
Dong Q; Liu YP; Qu XJ; Hou KZ; Li LL
Chin J Cancer; 2010 Jan; 29(1):59-64. PubMed ID: 20038312
[TBL] [Abstract][Full Text] [Related]
3. EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas.
Petrini I; Lencioni M; Vasile E; Fornaro L; Belluomini L; Pasquini G; Ginocchi L; Caparello C; Musettini G; Vivaldi C; Caponi S; Ricci S; Proietti A; Fontanini G; Naccarato AG; Nardini V; Santi S; Falcone A
Cancer Biomark; 2018 Feb; 21(3):731-741. PubMed ID: 29278885
[TBL] [Abstract][Full Text] [Related]
4. Relationship between expression of EGFR in gastric cancer tissue and clinicopathological features.
Gao M; Liang XJ; Zhang ZS; Ma W; Chang ZW; Zhang MZ
Asian Pac J Trop Med; 2013 Apr; 6(4):260-4. PubMed ID: 23608326
[TBL] [Abstract][Full Text] [Related]
5. Effect of EGFR and p-AKT Overexpression on Chromosomal Instability in Gastric Cancer.
Hisamatsu Y; Oki E; Otsu H; Ando K; Saeki H; Tokunaga E; Aishima S; Morita M; Oda Y; Maehara Y
Ann Surg Oncol; 2016 Jun; 23(6):1986-92. PubMed ID: 26847684
[TBL] [Abstract][Full Text] [Related]
6. Correlation of c-erbB-2, EGF and EGFR expression with postoperative survival of patients with advanced carcinoma of the stomach.
Czyzewska J; Guzinska-Ustymowicz K; Kemona A
Folia Histochem Cytobiol; 2009; 47(4):653-61. PubMed ID: 20430735
[TBL] [Abstract][Full Text] [Related]
7. Expression of Cbl linking with the epidermal growth factor receptor system is associated with tumor progression and poor prognosis of human gastric carcinoma.
Ito R; Nakayama H; Yoshida K; Matsumura S; Oda N; Yasui W
Virchows Arch; 2004 Apr; 444(4):324-31. PubMed ID: 14991403
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas.
Paliga A; Marginean H; Tessier-Cloutier B; Purgina B; Jonker D; Marginean EC
Am J Clin Oncol; 2017 Dec; 40(6):543-551. PubMed ID: 26125303
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.
Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
J Clin Pathol; 2018 May; 71(5):451-462. PubMed ID: 29138285
[TBL] [Abstract][Full Text] [Related]
10. HCRP1 downregulation confers poor prognosis and induces chemoresistance through regulation of EGFR-AKT pathway in human gastric cancer.
Xu H; Miao ZF; Wang ZN; Zhao TT; Xu YY; Song YX; Huang JY; Zhang JY; Liu XY; Wu JH; Xu HM
Virchows Arch; 2017 Dec; 471(6):743-751. PubMed ID: 28963677
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery.
Galizia G; Lieto E; Orditura M; Castellano P; Mura AL; Imperatore V; Pinto M; Zamboli A; De Vita F; Ferraraccio F
World J Surg; 2007 Jul; 31(7):1458-68. PubMed ID: 17516110
[TBL] [Abstract][Full Text] [Related]
12. EGFR, COX2, p-AKT expression and PIK3CA mutation in distal extrahepatic bile duct carcinoma.
Moon A; Chin S; Kim HK; Kwak JJ; Koh ES; Kim YW; Jang KT
Pathology; 2016 Jan; 48(1):35-40. PubMed ID: 27020207
[TBL] [Abstract][Full Text] [Related]
13. [Epidermal growth factor receptor and phosphorylated Akt protein expression in non-small-cell lung cancer].
Zhou ZL; Yang F; Jiang GC; Huang YQ; Fu J; Wang J
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1062-5. PubMed ID: 18754442
[TBL] [Abstract][Full Text] [Related]
14. [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
Liu C; Zhou S; Ke CS; Li NP; Wu RL
Ai Zheng; 2007 Sep; 26(9):929-36. PubMed ID: 17927847
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic studies of gefitinib in tumor biopsy specimens from patients with advanced gastric carcinoma.
Rojo F; Tabernero J; Albanell J; Van Cutsem E; Ohtsu A; Doi T; Koizumi W; Shirao K; Takiuchi H; Ramon y Cajal S; Baselga J
J Clin Oncol; 2006 Sep; 24(26):4309-16. PubMed ID: 16963731
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer.
Lee BL; Lee HS; Jung J; Cho SJ; Chung HY; Kim WH; Jin YW; Kim CS; Nam SY
Clin Cancer Res; 2005 Apr; 11(7):2518-25. PubMed ID: 15814628
[TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.
Lieto E; Ferraraccio F; Orditura M; Castellano P; Mura AL; Pinto M; Zamboli A; De Vita F; Galizia G
Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140
[TBL] [Abstract][Full Text] [Related]
18. High EGFR and low p-Akt expression is associated with better outcome after nimotuzumab-containing treatment in esophageal cancer patients: preliminary clinical result and testable hypothesis.
Wang CY; Deng JY; Cai XW; Fu XL; Li Y; Zhou XY; Wu XH; Hu XC; Fan M; Xiang JQ; Zhang YW; Chen HQ; Perez R; Jiang GL; Zhao KL
Oncotarget; 2015 Jul; 6(21):18674-82. PubMed ID: 26124180
[TBL] [Abstract][Full Text] [Related]
19. The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancer.
Eijsink JJ; Noordhuis MG; ten Hoor KA; Kok M; Hollema H; de Bock GH; Nijman HW; Schuuring E; Wisman GB; van der Zee AG
Hum Pathol; 2010 Dec; 41(12):1735-41. PubMed ID: 21078436
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of PI3K, Akt and survivin expression in gastric cancer.
Gu Y; Jin S; Wang F; Hua Y; Yang L; Shu Y; Zhang Z; Guo R
Biomed Pharmacother; 2014 May; 68(4):471-5. PubMed ID: 24726064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]